Johnson & Johnson (JNJ) Beats Lawsuit Alleging that Talc caused Three Women’s Ca

Johnson & Johnson (NYSE:JNJ) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.

On June 6, Reuters reported that a Los Angeles jury found Johnson & Johnson (NYSE:JNJ) was not negligent in a lawsuit alleging its talc products led to ovarian cancer in three women.

Reuters said the lawsuit was filed by the families of three women who died after using the company's talc-based baby powder. The report also pointed out that over 67,000 plaintiffs have filed similar lawsuits. The firm stopped selling talc-based baby powder in the US in 2020 and then switched to a cornstarch product.

Separately, on June 15, Johnson & Johnson (NYSE:JNJ) declared the commercial launch of its Dual Energy THERMOCOOL SMARTTOUCH SF Platform in Europe.

The healthcare firm said the platform delivers both radiofrequency and pulsed-field energy through a single catheter. It also noted 12-month SmartfIRE data showing 86.9% effectiveness. President Johnson & Johnson, Ricardo Martin said the platform gives physicians "greater confidence to tailor treatment to each patient's needs."

Johnson & Johnson (NYSE:JNJ) is a holding corporation that researches, develops, manufactures, and sel

Fuente original: Yahoo Finance (https://finance.yahoo.com/healthcare/articles/johnson-johnson-jnj-beats-lawsuit-195754103.html)